Antiretroviral Therapy, Highly Active
Clinical features and outcomes of AIDS-related cytomegalovirus retinitis in the era of highly active antiretroviral therapy
... after highly active antiretroviral therapy ...diagnosed, active AIDS-related cytomegalovirus retinitis, examined from January 2005 to December ...of highly active ...
6
Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy
... of highly active antiretroviral therapy (HAART) in HIV-infected patients has been associated with the development of risk factors for cardiovascular diseases (CD) including dyslipidemia and ...
6
Effectiveness of highly active antiretroviral therapy using non-brand name drugs in Brazil
... In Brazil, HIV-infected individuals receive drugs (including non- brand name drugs which comprise locally produced generics and drugs that have not been tested in bioequivalence trials) free of charge from the ...
5
Metabolic Effects Associated to the Highly Active Antiretroviral Therapy (HAART) in AIDS Patients
... with highly active antiretroviral therapy (HAART) in AIDS patients, treated in Campo Grande, Mato Grosso do Sul, ...without antiretroviral therapy; Group 2, with Zidovudine, ...
7
Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART)
... The aim of this study was to evaluate the genotypic resistance profiles of HIV-1 in children failing highly active antiretroviral therapy (HAART). Forty-one children (median age = 67 months) ...
5
The impact of highly active antiretroviral therapy on the survival of vertically hIV-infected children and adolescents in Belo horizonte, Brazil
... of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV)-infected pa- tients has reduced the number of acquired immune deficiency syndrome-related deaths ...
7
Enteric Parasitic Infections in HIVAIDS Patients Before and After the Highly Active Antiretroviral Therapy
... Enteroparasites are related to gastrointestinal alterations among patients with HIV/AIDS, some causing severe manifestations in the period before the institution of the highly active antiretroviral ...
8
Dyslipidemia in AIDS patients on highly active antiretroviral therapy
... Highly active antiretroviral therapy (HAART) reduces AIDS-related morbidity and mortality, how- ever it has been associated with metabolic ...
5
Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naive Patients at the Limbe Regional Hospital, Cameroon.
... of highly active antiretroviral therapy (HAART) greatly reduced the morbid- ity and mortality due to HIV/AIDS, with patients experiencing longer and healthier lives ...of antiretroviral ...
11
Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.
... All HIV+ subjects were on HAART and drug regimens were recorded for 95% of subjects. Seventy-eight percent of patients were on standard first line regimens consisting of two nucleoside (or nucleotide) analog reverse ...
7
Drogas antirretrovirais e pancreatite aguda em pacientes com HIV/AIDS: existe alguma associação? Revisão da literatura.
... (highly active antiretroviral therapy), o espectro de fatores nocivos ao pâncreas, como infecções oportunistas e uso de drogas para sua quimioprofilaxia, diminuiu ...
8
Cad. Saúde Pública vol.23 suppl.3
... Highly active antiretroviral therapy (HAART) has led to a substantial increase in the survival of people living with AIDS, despite heterogeneities among individuals from different ...
11
The evolving landscape of the economics of HIV treatment and prevention.
... accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western ...
2
The Influence of HCV Coinfection on Clinical, Immunological and Virological Responses to HAART in HIV-Patients
... Before the introduction of highly active antiretroviral therapy (HAART), HCV infection was not a relevant problem for the HIV-1 infected patients. However, as their life expectancy has ...
7
EFAVIRENZ-INDUCED GYNAECOMASTIA IN HIV INFECTED MALES: A REPORT OF 2 CASES
... INTRODUCTION: Highly active antiretroviral therapy (HAART) has revolutionised the treatment of HIV infected individuals, with reductions in morbidity and ...
4
STUDY OF ANTIRETROVIRAL MUTANTS IN HIV PATIENTS WITH TREATMENT FAILURES AND THE EFFECT OF RISK FACTORS IN THE VIROLOGICAL FAILURES
... There is extensive documentation about development of mutants resistant to highly active antiretroviral therapy (HAART), as well as its occurrence in certain individuals before treatment. ...
5
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME: A POTENTIAL PITFALL IN THE MANAGEMENT OF KAPOSI’S SARCOMA IN HIV POSITIVE PATIENTS? – A CASE REPORT
... of highly active antiretroviral therapy (HAART) is noteworthy, mainly in coun- tries that still have high levels of transmission of sexually transmitted diseases and ...and ...
5
HIV-1 Proviral DNA Loads (as Determined by Quantitative PCR) in Patients Subjected to Structured Treatment Interruption after Antiretroviral Therapy Failure
... 3. Chun TW, et al. 2002. Relationship between the size of the human im- munodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4⫹ T cells and CD4⫹:CD8⫹ T cell ratios in aviremic HIV-1-infected individ- uals ...
2
Cardiovascular disease associated with human immunodeficiency virus : a review
... of highly active antiretroviral therapy (HAART) ...of antiretroviral treatment on their regression, as well as the metabolic and cardiovascular implications of HAART regimens in ...
13
Recurring Candida albicans Esophagitis in a HIV-Infected Patient Undergoing Long-Term Antiretroviral Therapy, and with Absent-Negligible Immunodeficiency
... of highly active antiretroviral therapy (HAART) a dramatic drop of immunodeficiency-related opportunism occurred (especially for disorders associated with a CD4+ lymphocyte count below 50-100 ...
5